MUC1-C activates EZH2 expression and function in human cancer cells
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
MUC1-C activates EZH2 expression and function in human cancer cells
Authors
Keywords
-
Journal
Scientific Reports
Volume 7, Issue 1, Pages -
Publisher
Springer Nature
Online
2017-08-01
DOI
10.1038/s41598-017-07850-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- MUC1-C drives MYC in multiple myeloma
- (2016) Ashujit Tagde et al. BLOOD
- Inhibition of MUC1-C Suppresses MYC Expression and Attenuates Malignant Growth in KRAS Mutant Lung Adenocarcinomas
- (2016) Audrey Bouillez et al. CANCER RESEARCH
- Targeting EZH2 in cancer
- (2016) Kimberly H Kim et al. NATURE MEDICINE
- MUC1-C activates BMI1 in human cancer cells
- (2016) M Hiraki et al. ONCOGENE
- DNA methylation by DNMT1 and DNMT3b methyltransferases is driven by the MUC1-C oncoprotein in human carcinoma cells
- (2016) H Rajabi et al. ONCOGENE
- JMJD1A promotes tumorigenesis and forms a feedback loop with EZH2/let-7c in NSCLC cells
- (2016) Min Zhan et al. TUMOR BIOLOGY
- Epigenetic Reprogramming Sensitizes CML Stem Cells to Combined EZH2 and Tyrosine Kinase Inhibition
- (2016) M. T. Scott et al. Cancer Discovery
- Chronic Myelogenous Leukemia- Initiating Cells Require Polycomb Group Protein EZH2
- (2016) H. Xie et al. Cancer Discovery
- Functional interactions of the cystine/glutamate antiporter, CD44v and MUC1-C oncoprotein in triple-negative breast cancer cells
- (2016) Masanori Hasegawa et al. Oncotarget
- MUC1-C induces DNA methyltransferase 1 and represses tumor suppressor genes in acute myeloid leukemia
- (2016) Ashujit Tagde et al. Oncotarget
- Prognostic Significance of EZH2 Expression in Non-Small Cell Lung Cancer: A Meta-analysis
- (2016) Xinhua Wang et al. Scientific Reports
- MUC1-C Stabilizes MCL-1 in the Oxidative Stress Response of Triple-Negative Breast Cancer Cells to BCL-2 Inhibitors
- (2016) Masayuki Hiraki et al. Scientific Reports
- Intracellular Targeting of the Oncogenic MUC1-C Protein with a Novel GO-203 Nanoparticle Formulation
- (2015) M. Hasegawa et al. CLINICAL CANCER RESEARCH
- Identification of focally amplified lineage-specific super-enhancers in human epithelial cancers
- (2015) Xiaoyang Zhang et al. NATURE GENETICS
- MUC1-C activates the TAK1 inflammatory pathway in colon cancer
- (2015) H Takahashi et al. ONCOGENE
- Concurrent Targeting of KRAS and AKT by MiR-4689 Is a Novel Treatment Against Mutant KRAS Colorectal Cancer
- (2015) Masayuki Hiraki et al. Molecular Therapy-Nucleic Acids
- Enhancer of Zeste Homolog 2 as an Independent Prognostic Marker for Cancer: A Meta-Analysis
- (2015) Shuling Chen et al. PLoS One
- Characterization of the MUC1-C Cytoplasmic Domain as a Cancer Target
- (2015) Deepak Raina et al. PLoS One
- Myc Enforces Overexpression of EZH2 in Early Prostatic Neoplasia via Transcriptional and Post-transcriptional Mechanisms
- (2015) Cheryl M. Koh et al. Oncotarget
- Targeting the MUC1-C oncoprotein inhibits self-renewal capacity of breast cancer cells
- (2015) Maroof Alam et al. Oncotarget
- Understanding the relationship between DNA methylation and histone lysine methylation
- (2014) Nathan R. Rose et al. Biochimica et Biophysica Acta-Gene Regulatory Mechanisms
- TET1 Exerts Its Tumor Suppressor Function by Interacting with p53-EZH2 Pathway in Gastric Cancer
- (2014) Hua-Lin Fu et al. Journal of Biomedical Nanotechnology
- MUC1-C Induces the LIN28B→LET-7→HMGA2 Axis to Regulate Self-Renewal in NSCLC
- (2014) Maroof Alam et al. MOLECULAR CANCER RESEARCH
- EZH2 Protein Expression Associates with the Early Pathogenesis, Tumor Progression, and Prognosis of Non-Small Cell Lung Carcinoma
- (2013) C. Behrens et al. CLINICAL CANCER RESEARCH
- MUC1-C Oncoprotein Activates ERK→C/EBPβ Signaling and Induction of Aldehyde Dehydrogenase 1A1 in Breast Cancer Cells
- (2013) Maroof Alam et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The epigenetics of epithelial-mesenchymal plasticity in cancer
- (2013) Wai Leong Tam et al. NATURE MEDICINE
- MUC1-C oncoprotein activates the ZEB1/miR-200c regulatory loop and epithelial–mesenchymal transition
- (2013) H Rajabi et al. ONCOGENE
- Structure of the Catalytic Domain of EZH2 Reveals Conformational Plasticity in Cofactor and Substrate Binding Sites and Explains Oncogenic Mutations
- (2013) Hong Wu et al. PLoS One
- PRC2 overexpression and PRC2-target gene repression relating to poorer prognosis in small cell lung cancer
- (2013) Teruyuki Sato et al. Scientific Reports
- MUC1-C Oncoprotein Induces TCF7L2 Transcription Factor Activation and Promotes Cyclin D1 Expression in Human Breast Cancer Cells
- (2012) Hasan Rajabi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- MUC1-C oncoprotein as a target in breast cancer: activation of signaling pathways and therapeutic approaches
- (2012) D W Kufe ONCOGENE
- Mutation of A677 in histone methyltransferase EZH2 in human B-cell lymphoma promotes hypertrimethylation of histone H3 on lysine 27 (H3K27)
- (2012) M. T. McCabe et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Polycomb group protein EZH2 is frequently expressed in inflammatory breast cancer and is predictive of worse clinical outcome
- (2011) Yun Gong et al. CANCER
- MiR-26a Inhibits Cell Growth and Tumorigenesis of Nasopharyngeal Carcinoma through Repression of EZH2
- (2011) J. Lu et al. CANCER RESEARCH
- A Monoclonal Antibody Against the Oncogenic Mucin 1 Cytoplasmic Domain
- (2011) Govind Panchamoorthy et al. HYBRIDOMA
- Targeting cysteine-mediated dimerization of the MUC1-C oncoprotein in human cancer cells
- (2011) Donald Kufe INTERNATIONAL JOURNAL OF ONCOLOGY
- The Polycomb complex PRC2 and its mark in life
- (2011) Raphaël Margueron et al. NATURE
- Somatic mutations at EZH2 Y641 act dominantly through a mechanism of selectively altered PRC2 catalytic activity, to increase H3K27 trimethylation
- (2010) D. B. Yap et al. BLOOD
- Functional targeting of the MUC1 oncogene in human cancers
- (2010) Donald W. Kufe CANCER BIOLOGY & THERAPY
- Polycomb Group Proteins: Multi-Faceted Regulators of Somatic Stem Cells and Cancer
- (2010) Martin Sauvageau et al. Cell Stem Cell
- Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin
- (2010) Ryan D Morin et al. NATURE GENETICS
- MUC1-C Oncoprotein Functions as a Direct Activator of the Nuclear Factor- B p65 Transcription Factor
- (2009) R. Ahmad et al. CANCER RESEARCH
- Linking DNA methylation and histone modification: patterns and paradigms
- (2009) Howard Cedar et al. NATURE REVIEWS GENETICS
- MYC stimulates EZH2 expression by repression of its negative regulator miR-26a
- (2008) S. Sander et al. BLOOD
- E2F in vivo binding specificity: Comparison of consensus versus nonconsensus binding sites
- (2008) A. Rabinovich et al. GENOME RESEARCH
- Polycomb Complex 2 Is Required for E-cadherin Repression by the Snail1 Transcription Factor
- (2008) N. Herranz et al. MOLECULAR AND CELLULAR BIOLOGY
- Repression of E-cadherin by the polycomb group protein EZH2 in cancer
- (2008) Q Cao et al. ONCOGENE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now